ZAI LAB LIMITED |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.9 EUR | +1.27% |
|
-4.85% | -35.66% |
| 06-27 | Zai Lab Insider Sold Shares Worth $428,532, According to a Recent SEC Filing | MT |
| 06-20 | Zai Lab Grants ADSs to Independent Directors Under Incentive Scheme | MT |
Chart calendar Zai Lab Limited
050d508d6a534d2c2e.cZPQUfZjDZJEV3L5mGIxhEr_oqzG5Zy9oaLQ6FdE7BQ.EKuTAp1bV8NyCBae9gdI9jrN45S3j9nR08mHgD8pj14C8bQBgldu2A5lSg~2d5672179c7a5cb8013bfe8e2a06e987
Upcoming events on Zai Lab Limited
Past events on Zai Lab Limited
| 2024-06-18 08:00 | Annual General Meeting |
| 2024-06-12 13:20 | Goldman Sachs Global Healthcare Conference |
| 2024-06-05 15:30 | Jefferies Global Healthcare Conference |
| 2024-05-22 22:00 | J.P. Morgan Global China Summit |
| 2024-05-09 08:00 | Q1 2024 Earnings Call |
| 2024-05-08 16:05 | Q1 2024 Earnings Release |
| 2024-04-08 16:30 | American Association for Cancer Research Meeting - Progress 2, CT155 / 6 |
| 2024-04-08 16:30 | American Association for Cancer Research Meeting - Progress 2, CT162 / 13 |
| 2024-03-22 07:00 | European Lung Cancer Congress |
| 2024-03-18 18:24 | Society for Gynecologic Oncology Meeting |
| 2024-03-11 16:00 | Leerink Partners Global Biopharma Conference |
| 2024-03-09 10:13 | European Society of Gynaecological Oncology Meeting |
| 2024-02-28 08:00 | Q4 2023 Earnings Call |
| 2024-02-27 16:05 | Q4 2023 Earnings Release |
| 2024-01-08 18:45 | JPMorgan Healthcare Conference |
| 2023-11-29 12:55 | Evercore ISI HealthCONx Conference |
| 2023-11-15 08:00 | Jefferies London Healthcare Conference |
| 2023-11-08 08:00 | Q3 2023 Earnings Call |
| 2023-11-07 16:05 | Q3 2023 Earnings Release |
| 2023-09-27 08:00 | Cantor Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,0 9,26 40.23% | 49,0 56,3 -12.98% | 144 147 -2.08% | 215 216 -0.63% | 267 269 -0.77% | 393 |
|
EBITDA Million USD | Released Forecast Spread | -199 -145 -37.87% | -297 -249 -19.43% | -694 -614 -12.89% | -396 -425 6.86% | -358 -342 -4.68% | -313 |
|
EBIT Million USD | Released Forecast Spread | -203 -173 -17.38% | -302 -259 -16.31% | -700 -599 -16.82% | -404 -425 4.87% | -367 -351 -4.32% | -311 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -194 -120 -61.26% | -268 -259 -3.42% | -703 -613 -14.83% | -443 -463 4.37% | -335 -354 5.6% | -264 |
|
Net income Million USD | Released Forecast Spread | -195 -157 -23.93% | -269 -257 -4.55% | -704 -589 -19.52% | -443 -460 3.55% | -335 -348 3.74% | -270 |
|
EPS USD | Released Forecast Spread | -3,03 -2,61 -16.26% | -3,46 -3,18 -8.8% | -7,58 -6,87 -10.27% | -4,63 -4,93 6.02% | -3,46 -3,47 0.18% | -2,66 |
| Announcement Date | 19/03/20 | 01/03/21 | 01/03/22 | 01/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,56 14,8 -35.37% | 19,2 16,7 14.78% | 29,7 27,2 9.25% | 57,0 55,7 2.32% | 87,3 86,7 0.64% | 46,7 45,7 2.19% | 48,2 47,1 2.23% | 94,9 89,5 5.99% | 57,5 53,7 7.1% | 62,6 62,3 0.56% | 120 123 -2.04% | 62,8 65,5 -4.09% | 68,9 70,7 -2.56% | 69,2 66,7 3.84% | 65,8 72,1 -8.7% | 87,1 75,6 15.3% | 93,1 | 103 | 116 | 121 | 130 |
|
EBITDA Million USD | Released Forecast Spread | -77,8 -146 46.67% | -122 -81,0 -50.07% | -67,3 -105 36.09% | -67,9 | -66,6 | -62,3 | |||||||||||||||
|
EBIT Million USD | Released Forecast Spread | -117 -81,6 -43.84% | -130 -125 -4.58% | -172 -147 -16.57% | -398 -391 -1.6% | -302 -290 -4.16% | -79,8 -120 33.75% | -98,7 -102 2.9% | -178 -179 0.28% | -129 -112 -14.47% | -97,3 -108 10.22% | -226 -256 11.89% | -69,5 -93,3 25.51% | -89,5 -88,8 -0.84% | -83,6 -103 19.02% | -124 -89,0 -39.31% | -70,3 -98,5 28.6% | -74,6 | -71,5 | -77,3 | -56,3 | -51,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -111 -93,0 -19.79% | -128 -130 1.57% | -140 -145 3.81% | -82,2 -89,1 7.77% | -138 -103 -34.44% | -161 -125 -29.02% | -61,8 -106 41.95% | -49,1 -90,2 45.54% | -121 -72,8 -66.06% | -69,2 -89,0 22.3% | -95,4 -81,0 -17.77% | -53,5 -93,1 42.55% | -66,6 | -62,5 | -62,5 | -48,5 | -44,5 | ||||
|
Net income Million USD | Released Forecast Spread | -112 -92,8 -20.47% | -129 -130 1.35% | -140 -145 3.32% | -82,4 -117 29.43% | -138 -102 -35.39% | -161 -122 -31.74% | -61,8 -107 42.22% | -223 -183 -21.84% | -49,1 -90,0 45.41% | -121 -72,3 -67.14% | -69,2 -91,2 24.15% | -95,4 -84,8 -12.57% | -53,5 -91,7 41.69% | -68,5 | -65,8 | -66,0 | -48,5 | -44,5 | |||
|
EPS USD | Released Forecast Spread | -1,66 -1,42 -16.9% | -1,74 -1,75 0.29% | -1,72 -1,71 -0.39% | -0,86 -1,14 24.78% | -1,44 -1,06 -35.96% | -1,68 -1,27 -32.43% | -0,65 -1,12 41.72% | -0,51 -0,93 45.31% | -1,25 -0,75 -67.66% | -0,71 -0,94 24.44% | -0,98 -0,87 -12.69% | -0,55 -0,94 41.43% | -0,70 | -0,67 | -0,68 | -0,50 | -0,46 | ||||
| Announcement Date | 19/03/20 | 13/08/20 | 01/03/21 | 09/08/21 | 01/03/22 | 10/05/22 | 09/08/22 | 09/08/22 | 09/11/22 | 01/03/23 | 01/03/23 | 09/05/23 | 07/08/23 | 07/11/23 | 27/02/24 | 08/05/24 | - | - | - | - | - |
| 2024-07-11 02:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 2024-07-23 02:00 | BIOGAIA AB: Q2 2024 Earnings Release |
| 2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-25 01:00 | UCB: Q2 2024 Earnings Release |
| 2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | INCYTE CORPORATION: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | GRIFOLS, S.A.: Q2 2024 Earnings Release |
Past sector events for Zai Lab Limited
| 2024-05-23 05:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 11:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 2024-05-13 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 02:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
| 2024-05-08 16:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZLAB Stock
- 1ZL Stock
- Calendar Zai Lab Limited
